CVS Health Raises Full-Year Adjusted EPS Guidance to at Least $8.20, Up from $7.90–$8.10; Consensus $8.05
U.S. healthcare company CVS raised its full-year adjusted EPS guidance to at least $8.20, up from the prior range of $7.90–$8.10; the market consensus was $8.05.
VolFlash analysisQueued
This event is in the analysis queue — usually done within 40s. Refresh to see it.
Unified event
5 reports
5 outlets reported the same event; merged into one entry with a single analysis.
- wallstcn美国9月贸易帐 -1050亿美元，预期 -1079亿美元，前值 -1056亿美元。13:30
- wallstcn美国将季度再融资规模定为1250亿美元，与预期一致。 美国财政部定于11月9日举行三年期国债拍卖，规模为580亿美元。13:31
- wallstcn美国将季度再融资规模定为1250亿美元，与预期一致。 美国财政部将拍卖580亿美元三年期债券；420亿美元十年期债券；213:31
- wallstcn加拿大9月贸易顺差扩大至四年多以来最高水平14:00
One email a day — don't miss the big ones
The 8 highest-severity events of the past 24h, with our read and source links. Unsubscribe anytime.
Related events
Published：2026-11-04 11:32:18 · Source：wallstcn · Automatically aggregated and analysed — verify against the original source.